Combination Regimen of Teniposide, PD-1 Monoclonal Antibody and Selinixor for Patients With Relapsed or Refractory PCNSL
Abroad (travel likely)Recruiting
Conditions
Primary Central Nervous System Lymphoma (PCNSL)
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China